On August 23, 2021, the FDA granted approval to the Pfizer-BioNTech COVID-19 vaccine. The approved vaccine, now to be marketed as Comirnaty, has been approved for the prevention of COVID-19 in individuals 16 years of age and older. The vaccine will continue to be available under emergency use authorization (EUA) for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals. Additionally, the Moderna vaccine has completed its application process for full approval, putting the vaccine on course to obtain FDA approval, which we could see within the next few weeks.

View PDF